CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-20 | Gagnon Robert E. Chief Financial Officer | Sale | −5,497 | $2.27 | $12K | 578,901 |
| 2021-12-15 | Paterson Dan President and COO | Grant or award | +181,500 | 515,279 | ||
| 2021-12-15 | Paterson Dan President and COO | Grant or award · Stock Option (Right to Buy) | +368,500 | 368,500 | ||
| 2021-12-15 | Gagnon Robert E. Chief Financial Officer | Grant or award | +148,500 | 584,398 | ||
| 2021-12-15 | Gagnon Robert E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +301,500 | 301,500 | ||
| 2021-12-15 | Stuglik Brian M Chief Executive Officer | Grant or award | +363,000 | 1,182,381 | ||
| 2021-12-15 | Stuglik Brian M Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +737,000 | 737,000 | ||
| 2021-11-15 | ROBERTSON MICHELLE Director | Grant or award · Stock Option (right to buy) | +63,493 | 63,493 | ||
| 2021-11-01 | Stuglik Brian M Chief Executive Officer | Shares withheld for taxes | −5,839 | $2.59 | $15K | 819,381 |
| 2021-08-12 | Paterson Dan President and COO | Shares withheld for taxes | −50,244 | $2.87 | $144K | 333,779 |
| 2021-08-12 | Gagnon Robert E. Chief Financial Officer | Shares withheld for taxes | −45,329 | $2.87 | $130K | 435,898 |
| 2021-06-28 | JOHNSON JOHN Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-06-28 | Consylman Gina Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-06-28 | Rowinsky Eric K Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-06-28 | BARBERICH TIMOTHY J Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-06-28 | Kauffman Michael Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-06-24 | Solomon Lesley Kim Director | Grant or award · Stock Option (right to buy) | +73,356 | 73,356 | ||
| 2021-06-24 | Bunn Paul A. Director | Grant or award · Stock Option (right to buy) | +73,356 | 73,356 | ||
| 2021-03-25 | Stuglik Brian M Chief Executive Officer | Grant or award | +191,828 | 1,186,185 | ||
| 2021-01-06 | Neumann Frank Chief Medical Officer | Grant or award | +150,000 | 150,000 |
Page 16 of 17 · 326 trades